Doctor profile · Federal record
Dr. Mark Jalkut, MD
Urology Physician (CMS: Urology) · Raleigh, NC
- NPI 1326054859
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 33 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3821 Ed Dr
Raleigh, NC 276128038
(919) 782-1255
fax (919) 782-6550
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- January 7, 2021
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 208800000X — NUCC code
- State license (1)
- North Carolina #200401230
- Medicaid
- NC #891377V
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1326054859. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
14,545
Distinct HCPCS
10
Medicare allowed
$371,218
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,650 | 37 | $0 | |
J9155 |
Injection, degarelix, 1 mg | 3,120 | 11 | $4 | |
J0897 |
Injection, denosumab, 1 mg | 2,820 | 12 | $23 | |
82570 |
Creatinine level to test for kidney function or muscle injury | 963 | 585 | $5 | |
81003 |
Automated urinalysis test | 674 | 450 | $2 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 658 | 438 | $122 | |
84153 |
Psa (prostate specific antigen) measurement, total | 525 | 375 | $18 | |
81001 |
Manual urinalysis test with examination using microscope, automated | 342 | 231 | $3 | |
J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg | 237 | 28 | $170 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 222 | 190 | $87 |
In context: peer comparison
Among 14 peers in this city , average services per provider: 232. This provider delivers 63× the peer median.Open Payments
Industry payments received
All-time total
$2,005
Transactions
74
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | 33 | $859.23 | |
| Sumitomo Pharma America, Inc. | 13 | $269.55 | |
| INTUITIVE SURGICAL, INC. | 2 | $150.53 | |
| CONMED Corporation | 1 | $124.99 | |
| Astellas Pharma US Inc | 1 | $115.43 | |
| PROGENICS PHARMACEUTICALS, INC. | 4 | $87.30 | |
| Blue Earth Diagnostics Limited | 4 | $80.46 | |
| PFIZER INC. | 3 | $67.95 | |
| UROGEN PHARMA, INC. | 3 | $57.91 | |
| Janssen Biotech, Inc. | 2 | $51.21 | |
| Myriad Genetic Laboratories, Inc. | 3 | $42.68 | |
| Merck Sharp & Dohme LLC | 2 | $35.42 | |
| Endo USA, Inc. | 1 | $22.48 | |
| IMMUNITYBIO, INC. | 1 | $21.00 | |
| ABBVIE INC. | 1 | $18.83 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,499
Patients
518
Total drug cost
$2,419,159
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tamsulosin Hcl | Generic | 559 | 193 | $11,797 |
| Finasteride | Generic | 119 | 36 | $2,249 |
| Xtandi (Enzalutamide) | Brand | 112 | 14 | $1,576,306 |
| Myrbetriq (Mirabegron) | Brand | 103 | 27 | $106,491 |
| Cefdinir | Generic | 89 | 81 | $930 |
| Solifenacin Succinate | Generic | 77 | 23 | $4,555 |
| Prednisone | Generic | 63 | 0 | $222 |
| Potassium Citrate Er (Potassium Citrate) | Brand | 61 | 19 | $10,994 |
| Testosterone Cypionate | Generic | 59 | 12 | $2,438 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 48 | 46 | $241 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Jalkut's medical specialty?
Dr. Mark Jalkut practices Urology Physician in Raleigh, NC.
Where does Dr. Mark Jalkut practice?
Dr. Mark Jalkut practices at 3821 Ed Dr, Raleigh, NC 276128038. Office phone: 9197821255.
What is Dr. Mark Jalkut's NPI?
Dr. Mark Jalkut's National Provider Identifier (NPI) is 1326054859, issued by NPPES.
Does Dr. Mark Jalkut accept Medicare assignment?
Yes. Dr. Mark Jalkut accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Jalkut commonly perform?
Top Medicare-reported procedures in 2023: Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967); Injection, degarelix, 1 mg (HCPCS J9155); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.